Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39


Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats.

Huang K, Wang Z, Gu Y, Hu Y, Ji Z, Wang S, Lin Z, Li X, Xie Z, Pan S.

J Am Heart Assoc. 2016 Jul 13;5(7). pii: e003465. doi: 10.1161/JAHA.116.003465.


Changes in cardiac arrest patients' temperature management after the 2013 "TTM" trial: results from an international survey.

Deye N, Vincent F, Michel P, Ehrmann S, da Silva D, Piagnerelli M, Kimmoun A, Hamzaoui O, Lacherade JC, de Jonghe B, Brouard F, Audoin C, Monnet X, Laterre PF; SRLF Trial Group..

Ann Intensive Care. 2016 Dec;6(1):4. doi: 10.1186/s13613-015-0104-6.


Variability in Postarrest Targeted Temperature Management Practice: Implications of the 2015 Guidelines.

Leary M, Blewer AL, Delfin G, Abella BS.

Ther Hypothermia Temp Manag. 2015 Dec;5(4):184-7. doi: 10.1089/ther.2015.0027.


Association between treatment at an ST-segment elevation myocardial infarction center and neurologic recovery after out-of-hospital cardiac arrest.

Mumma BE, Diercks DB, Wilson MD, Holmes JF.

Am Heart J. 2015 Sep;170(3):516-23. doi: 10.1016/j.ahj.2015.05.020.


Effect of a pharmacologically induced decrease in core temperature in rats resuscitated from cardiac arrest.

Katz LM, Frank JE, Glickman LT, McGwin G Jr, Lambert BH, Gordon CJ.

Resuscitation. 2015 Jul;92:26-31. doi: 10.1016/j.resuscitation.2015.04.009.


Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage.

Chung TN, Kim JH, Choi BY, Chung SP, Kwon SW, Suh SW.

Stem Cells Transl Med. 2015 Feb;4(2):178-85. doi: 10.5966/sctm.2014-0103.


Availability and utilization of cardiac resuscitation centers.

Mumma BE, Diercks DB, Holmes JF.

West J Emerg Med. 2014 Nov;15(7):758-63. doi: 10.5811/westjem.2014.8.21877.


Extracranial hypothermia during cardiac arrest and cardiopulmonary resuscitation is neuroprotective in vivo.

Hutchens MP, Fujiyoshi T, Koerner IP, Herson PS.

Ther Hypothermia Temp Manag. 2014 Jun;4(2):79-87. doi: 10.1089/ther.2014.0003.


Clinical applications of targeted temperature management.

Perman SM, Goyal M, Neumar RW, Topjian AA, Gaieski DF.

Chest. 2014 Feb;145(2):386-93. doi: 10.1378/chest.12-3025. Review.


Early coronary angiography and induced hypothermia are associated with survival and functional recovery after out-of-hospital cardiac arrest.

Callaway CW, Schmicker RH, Brown SP, Albrich JM, Andrusiek DL, Aufderheide TP, Christenson J, Daya MR, Falconer D, Husa RD, Idris AH, Ornato JP, Rac VE, Rea TD, Rittenberger JC, Sears G, Stiell IG; ROC Investigators..

Resuscitation. 2014 May;85(5):657-63. doi: 10.1016/j.resuscitation.2013.12.028.


Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Ning MM, Lopez M, Sarracino D, Cao J, Karchin M, McMullin D, Wang X, Buonanno FS, Lo EH.

Neurol Res. 2013 Jun;35(5):448-56. doi: 10.1179/1743132813Y.0000000213. Review.


Post-cardiac arrest therapeutic hypothermia in New Jersey hospitals: analysis of adoption and implementation.

DeLia D, Wang HE, Kutzin J, Merlin M, Cantor JC.

Ther Hypothermia Temp Manag. 2012 Jun;2(2):78-88.


Induction of a prolonged hypothermic state by drug-induced reduction in the thermoregulatory set-point.

Katz LM, Frank JE, McGwin G Jr, Finch A, Gordon CJ.

Ther Hypothermia Temp Manag. 2012 Jun;2(2):61-6.


H(2) gas improves functional outcome after cardiac arrest to an extent comparable to therapeutic hypothermia in a rat model.

Hayashida K, Sano M, Kamimura N, Yokota T, Suzuki M, Maekawa Y, Kawamura A, Abe T, Ohta S, Fukuda K, Hori S.

J Am Heart Assoc. 2012 Oct;1(5):e003459. doi: 10.1161/JAHA.112.003459.


Therapeutic hypothermia for out-of-hospital cardiac arrest: An analysis comparing cooled and not cooled groups at a Canadian center.

Maclean DA, Stevenson RS, Bata I, Green RS.

J Emerg Trauma Shock. 2012 Oct;5(4):328-32. doi: 10.4103/0974-2700.102403.


The practice of therapeutic hypothermia after cardiac arrest in France: a national survey.

Orban JC, Cattet F, Lefrant JY, Leone M, Jaber S, Constantin JM, Allaouchiche B, Ichai C; AzuRéa group..

PLoS One. 2012;7(9):e45284. doi: 10.1371/journal.pone.0045284.


Therapeutic hypothermia for cardiac arrest: real-world utilization trends and hospital mortality.

Jena AB, Romley JA, Newton-Cheh C, Noseworthy P.

J Hosp Med. 2012 Nov-Dec;7(9):684-9. doi: 10.1002/jhm.1974.


The effect of hypothermia "dose" on vasopressor requirements and outcome after cardiac arrest.

Huynh N, Kloke J, Gu C, Callaway CW, Guyette FX, Gebhardt K, Alvarez R, Tisherman SA, Rittenberger JC.

Resuscitation. 2013 Feb;84(2):189-93. doi: 10.1016/j.resuscitation.2012.06.011.


Is there still a place for vasopressors in the treatment of cardiac arrest?

Sandroni C, Cavallaro F, Antonelli M.

Crit Care. 2012 Dec 12;16(2):213. doi: 10.1186/cc11227. Review. No abstract available.

Items per page

Supplemental Content

Support Center